Form 4 Filing for Teri L. Lawver at Celldex Therapeutics, Inc.

On June 25, 2026, Teri L. Lawver, SVP & Chief Commercial Officer at Celldex Therapeutics, Inc. (CLDX), was granted 90,000 Incentive Stock Options under the company's 2021 Omnibus Equity Incentive Plan. These options have an exercise price of $34.09 and an expiration date of June 25, 2036. The options vest starting June 25, 2027, with 25% vesting on that date, and the remaining 75% vesting quarterly over the subsequent 12 quarters. Ms. Lawver has a direct ownership interest in these options, and post-transaction, she holds 90,000 shares underlying these options.